Bioclone

Bioclone: 100 % natural cuttings gel. For optimal development of cuttings. Promotes rapid rooting and stimulates growth of the Cannabis Light plant.

Bioclone by BAC organic product for cuttings.
BAC’s BioClone is a 100% organic gel for making cuttings. Cloning Cannabis Light plants has never been easier with this natural product.

With this gel you can produce large quantities of Cannabis Light cuttings with a high success rate. Simply cut clones with at least 2 layers of leaves from the selected Cannabis Light plant, soak them 60 seconds in the gel and place them in the substrate where rooting will take place. Can be used directly in soil, however we recommend using a sterile substrate such as jiffys or rockwool cubes.

How is BAC Bioclone used in cultivation?
To ensure a good result place the Cannabis Light cuttings in a suitable environment, such as a propagator box to be kept closed for a couple of days, with 99% humidity and 22ºC. After this time we open the windows a little to lower the humidity to 70%, maintaining a constant spring temperature. Many mini-propagator models have these side openings as standard to regulate ventilation. In about 3 days we will notice the start of vegetative growth of the Cannabis Light plant and it will then be the perfect time to transplant it into a larger container or pot.

BAC’s BioClone 100% organic and environmentally safe.

Curiosity:

Here’s why Raphael Mechoulam, father of cannabis research, deserves a Nobel Prize

Who is Professor Raphael Mechoulam

Born in 1930 in Sofia, Bulgaria, Raphael Mechoulam is a naturalised Israeli chemist and biologist. After moving to Israel with his family in 1949, Mechoulam obtained a doctorate in chemistry and then moved to Manhattan to take a postgraduate course at Rockefeller University, a private university dedicated primarily to medical and scientific research.

At the end of his studies, Mechoulam returned to Israel, where he became a member of the Weizmann Institute, one of the most important research centres in the world, and it was there that he first succeeded, in 1964, in isolating and synthesising Delta 9 tetrahydrocannabinol, the most important active ingredient in cannabis. After being appointed professor of chemistry at the Hebrew University of Jerusalem, Mechoulam continued his studies on cannabis by identifying cannabidiol (CBD) and cannabigerol (CBG) and isolating the endocannabinoid anandamide and 2-arachidonoylglycerol (2-AG), all milestones in the study of cannabis that led to the creation in his honour of the ‘Raphael Mechoulam Annual Award in Cannabinoid Research’, a prestigious industry award instituted by the International Cannabinoid Research Society.

The synthesis of EPM301

In addition to these discoveries, in 2020 Raphael Mechoulam succeeded in creating a new synthetic cannabinoid: the methyl ester of cannabidiolic acid, also known as EPM301. Among its main properties is its ability to suppress anxiety and nausea, two characteristics that make it medically and therapeutically essential. Currently, EPM301 has been approved for human trials led by the US Food and Drug Administration for the treatment of inflammatory bowel disease (IBS), psoriasis and acute respiratory distress syndrome (ARDS)…